BIENAIME JEAN JACQUES

CIK 1221590
Transactions on file
27
Open-market buys
19
Win rate (buys)
63%
19 scored
Avg % since filing (buys)
+17.0%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-08-192026-08-17KROS
Keros Therapeutics, Inc.
Buy1,000$10.3K+9.0%open →
2026-08-192026-08-14ASND
Ascendis Pharma A/S
Buy900$222.2K-0.7%open →
2026-08-192026-08-14ASND
Ascendis Pharma A/S
Buy1,100$270.4K-0.3%open →
2026-07-172026-07-15KROS
Keros Therapeutics, Inc.
Buy1,000$10.6K+5.5%open →
2026-06-172026-06-15KROS
Keros Therapeutics, Inc.
Buy1,000$10.2K+9.8%open →
2026-06-102026-06-08INCY
INCYTE CORP
Director
Grant1,642$0.00—open →
2026-06-092026-06-05IMNM
Immunome Inc.
Buy1,000$19.3K-10.7%open →
2026-06-092026-06-05IMNM
Immunome Inc.
Buy3,500$68.1K-11.6%open →
2026-06-092026-06-05IMNM
Immunome Inc.
Buy6,000$116.9K-11.7%open →
2026-06-092026-06-05IMNM
Immunome Inc.
Sale10,000$194.1K-11.4%open →
2026-06-092026-06-05IMNM
Immunome Inc.
Sale500$9.7K-11.5%open →
2026-06-052026-06-03KROS
Keros Therapeutics, Inc.
Grant7,142$0.00—open →
2026-06-012026-05-29ASND
Ascendis Pharma A/S
Buy100$22.4K+9.7%open →
2026-06-012026-05-29ASND
Ascendis Pharma A/S
Buy200$44.5K+10.3%open →
2026-06-012026-05-29ASND
Ascendis Pharma A/S
Buy200$44.8K+9.6%open →
2026-05-282026-05-26INCY
INCYTE CORP
Director
Tax13,059$1.27M+20.4%open →
2026-05-282026-05-26INCY
INCYTE CORP
Director
Exer.15,000$1.27M+38.3%open →
2026-05-272026-05-26ASND
Ascendis Pharma A/S
Buy200$47.9K+2.4%open →
2026-05-272026-05-26ASND
Ascendis Pharma A/S
Buy200$47.2K+3.8%open →
2026-05-192026-05-15KROS
Keros Therapeutics, Inc.
Buy1,000$10.6K+5.8%open →
2026-05-192026-05-15IMNM
Immunome Inc.
Buy5,000$103.5K-16.9%open →
2026-04-172026-04-15KROS
Keros Therapeutics, Inc.
Buy1,000$11.7K-4.4%open →
2025-03-252025-03-24IMNM
Immunome Inc.
Director
Buy7,000$57.5K+109.5%open →
2025-03-262025-03-25IMNM
Immunome Inc.
Director
Buy7,800$60.7K+121.1%open →
2025-06-032025-06-03IMNM
Immunome Inc.
Director
Buy5,000$46.9K+83.4%open →
2025-06-062025-06-04KROS
Keros Therapeutics, Inc.
Director
Grant5,250$0.00—open →
2025-06-122025-06-10INCY
INCYTE CORP
Director
Grant2,518$0.00—open →